Sonoma Pharmaceuticals (United States)

Sonoma Pharmaceuticals develops and markets unique prescription and non-prescription products using its proprietary hypochlorous acid technology. The company’s products treat chronic wounds, dermatological conditions, eye infections, and other conditions using its Microcyn and Nanocyn platforms. Sonoma’s antimicrobial solutions offer novel approaches to infection control and wound healing.